Search Results 221-230 of 18161 for Lymphocytic leukemia

  1. CAR-T Cell Therapy Program - Department home - Mayo Clinic

    CAR-T cell therapy may be a treatment option for: Relapsed, refractory B-cell acute lymphoblastic leukemia; Relapsed, refractory B-cell non-Hodgkin's lymphoma ...

  2. Bone Marrow Transplant Program - Doctors - Mayo Clinic

    Allogeneic stem cell transplant, Acute lymphocytic leukemia, Myelodysplastic syndromes, Acute myelogenous leukemia, Chr...onic myelogenous leukemia ...

  3. Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia - Mayo Clinic

    This study is designed to evaluate PFS endpoint for acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia. Participation eligibility.

  4. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Giving Akt inhibitor MK2206 with bendamustine hydrochloride and rituximab may be an effective treatment for chronic lymphocytic leukemia or small lymphocytic ...

  5. A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT) - Mayo Clinic

    Acute lymphoblastic leukemia (ALL); Acute undifferentiated leukemia (AUL) ... Chronic lymphocytic leukemia (CLL). A defined myelodysplastic syndrome(s) ...

  6. A Study Comparing Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    ... lymphocytic leukemia. Ibrutinib may stop the growth of cancer cells by ... Giving ibrutinib, obinutuzumab and venetoclax may work better in treating patients with ...

  7. Acute Myelogenous Leukemia Clinical Trials - Mayo Clinic Research

    ... leukemia or acute lymphoblastic leukemia. (Phase I closed to enrollment as of 09/16/09). WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating ...

  8. Splenectomy - Mayo Clinic

    Splenectomy may treat cancers including chronic lymphocytic leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma and hairy cell leukemia. Infection. Having a ...

  9. Madiha Iqbal, M.B.B.S., M.D.

    Conditions treated · Acute myelogenous leukemia · B-cell lymphoma · Burkitt lymphoma · Chronic lymphocytic leukemia · Follicular lymphoma · Hodgkin lymphoma · Non- ...

  10. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined Regimen Of Mosunetuzumab And Venetoclax In Participants With Relapsed Or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    ... lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring ...